Centargo compatible with Ultravist® (iopromide), Isovue® (iopamidol), Optiray® (ioversol), Omnipaque™ (iohexol) and now, Visipaque™ (iodixanol) Follows recent FDA clearance to expand the use of ...

Bayer announced today 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its MEDRAD ® Centargo CT Injection System, an innovative multi-patient injector that drives workflow ...

The FDA grants 510(k) clearance to Bayer's (OTCPK:BAYRY +0.1%) MEDRAD Stellant FLEX Computed Tomography (CT) Injection System with Certegra Workstation for use in Contrast Enhanced Mammography (CEM).

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global contrast injectors market since 2015 and the market is poised to grow by USD 613.47 million during 2020-2024, progressing at a CAGR of ...

Bayer today announced that its MEDRAD® Centargo multi-patient CT injector has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the use of compatible contrast agent ...

Follows recent FDA clearance to expand the use of compatible contrast agent presentations, adding single-dose vials in addition to Imaging Bulk Package presentations Radiology suites now have the ...